Advocates told Georgia lawmakers on Thursday that the state's narrow medical cannabis laws block thousands of residents with chronic conditions from effective treatment. At Mercer University, speakers urged expansion of the 2019 Hope Act, which limits eligibility to terminal illnesses and requires non-smokable products from just three licensed dispensaries. With only about 30,000 patients enrolled, critics argue these restrictions drive people to illegal markets or neighboring states.
Current Limits Frustrate Patients and Providers
The Hope Act confines Georgia's Low-THC Medical Cannabis Program to patients with terminal conditions, supplied solely by state-licensed outlets like Fine Fettle in Macon. Judson Hill, Fine Fettle's Georgia Market President, told the committee that these rules prevent broader access to treatments for various ailments. Non-smokable forms such as edibles and topicals dominate, excluding inhalable options that advocates say deliver faster relief for acute symptoms.
Legislative Push Seeks Balanced Reform
The Georgia House Blue Ribbon Study Committee on Medical Marijuana and Hemp Policies, chaired by physician State Rep. Mark Newton (R-Augusta), is touring the state to gather input. Newton supports wider access but stresses safeguards for youth, insisting on precise conditions, recommendations, and medical oversight. Expansion bills faltered in the 2025 legislative session, but committee findings will shape 2026 proposals.
Path Forward Balances Health Needs and Safeguards
Hill emphasized that safe, tested cannabis grown in Georgia remains underutilized, pushing patients toward riskier alternatives. Evolving perceptions of cannabis could unlock public health benefits, aligning Georgia with states offering broader medical programs. As the committee collects testimony, lawmakers face pressure to reconcile patient demands with protections against youth access and unregulated use.
